Deafness caused by a faulty gene is permanent; nothing can restore the hearing
The old claim turned out to be wrong and was rejected by evidence.
TaughtWhen a child is born deaf because of a genetic defect, the ear is broken at the source. A cochlear implant can route sound around the damage, but there is no way to fix the underlying biology and give the ear its own hearing back.
NowOn 23 April 2026 the FDA approved Otarmeni (lunsotogene parvec), a one-time gene therapy for deafness caused by variants in the OTOF gene. It delivers a working copy of the gene to the inner ear, and most treated patients gained usable hearing, some reaching normal levels, including whispers.
What actually happened
OTOF-related deafness is a clean target because the defect is a single missing protein, otoferlin, that the hair cells need to pass sound signals to the nerve. The hair cells themselves are intact; they just cannot talk. Deliver a good copy of the gene and, in principle, the ear starts working. Otarmeni does exactly that, surgically dripped into the cochlea in a single procedure.
The honest boundaries matter. This treats one rare genetic cause, not the many other reasons people are deaf, and it is not a pill; it is inner-ear surgery with an experimental biologic, approved on accelerated terms with confirmatory data still to come. But the flat classroom statement, that inherited deafness is a permanent fact of the body, is the thing that broke. Regeneron is even providing it free in the US, which tells you how small and specific the eligible group is. What changed is the category: for at least one kind of genetic deafness, the ear can now be repaired rather than bypassed.
Newsletter
Get new weekly revisions
Sources
Who was taught this
Still standard through 2026, so anyone who finished school between 1950 and 2026 learned the earlier version.